• Price (USD)599.49
  • Today's Change-8.71 / -1.43%
  • Shares traded8.23k
  • 1 Year change+32.27%
  • Beta1.5828
Data delayed at least 15 minutes, as of Oct 21 2021 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Align Technology, Inc. designs, manufactures and markets Invisalign clear aligners and iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for dental laboratories and dental practitioners. It operates through two segments: Clear Aligner segment and Imaging Systems and CAD/CAM services (Systems and Services) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Invisalign Moderate, Lite and Express packages and Invisalign Go (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Systems and Services segment consists of its iTero intraoral scanning systems, which includes a hardware platform and restorative or orthodontic software options, OrthoCAD services and ancillary products, as well as exocad’s CAD/CAM software solution.

  • Revenue in USD (TTM)3.47bn
  • Net income in USD698.45m
  • Incorporated1997
  • Employees18.07k
  • Location
    Align Technology Inc410 NORTH SCOTTSDALE ROAD, SUITE 1300TEMPE 85281United StatesUSA
  • Phone+1 (408) 470-1000
  • Fax+1 (408) 470-1010
  • Websitehttp://www.aligntech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
West Pharmaceutical Services Inc.2.52bn519.20m31.24bn9.20k61.7115.3751.1212.386.846.8433.2227.470.94734.936.14274,184.8018.6311.0122.1613.0139.3533.2819.6712.682.3972.830.111118.3316.698.9343.2429.355.797.63
Zimmer Biomet Holdings Inc7.89bn931.90m31.50bn20.00k33.812.5015.793.994.464.3937.7060.270.32960.92056.35394,445.003.910.90274.381.0170.6670.9311.862.990.96436.300.384385.08-12.003.21-117.62---1.161.76
ResMed Inc.3.20bn474.51m38.32bn7.97k81.2313.2860.4011.993.243.2421.8719.810.68643.105.76401,107.3010.1911.9812.1714.0357.6957.6614.8417.491.2326.340.185145.578.1111.70-23.676.1311.495.39
Baxter International Inc12.20bn1.12bn40.72bn50.00k37.354.7920.443.342.182.1823.7416.990.62313.716.25243,940.005.7810.836.8913.3139.5741.889.2717.191.7812.870.419520.452.743.2136.5622.90-4.89-5.54
Align Technology, Inc.3.47bn698.45m47.37bn18.07k68.3213.9859.2713.638.778.7743.6642.870.73755.775.42192,265.8014.8329.3220.5942.4474.2773.2820.1033.471.21--
DexCom, Inc.2.17bn530.60m54.96bn5.50k106.3927.5089.5525.335.345.3421.8220.660.54072.695.56394,527.3013.225.7815.116.7869.9666.0924.457.985.254.020.46950.0030.5436.81388.23--42.98--
Boston Scientific Corporation11.20bn526.00m63.89bn38.00k122.014.0039.245.710.36780.36787.8311.210.36132.557.15294,657.901.883.032.133.7866.4569.705.217.171.31--0.36360.00-7.665.80-119.23--0.3484--
Becton Dickinson and Co19.90bn1.87bn70.78bn72.00k38.712.9317.283.566.376.3767.8884.040.36753.569.77276,333.303.612.434.142.7747.2746.949.836.780.85067.400.423680.41-1.0010.73-25.681.995.055.66
Data as of Oct 21 2021. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

36.13%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20216.51m8.24%
Edgewood Management LLCas of 30 Jun 20214.47m5.66%
BlackRock Fund Advisorsas of 30 Jun 20213.60m4.56%
SSgA Funds Management, Inc.as of 30 Jun 20212.98m3.77%
Sands Capital Management LLCas of 30 Jun 20212.89m3.66%
Wellington Management Co. LLPas of 30 Jun 20211.89m2.39%
AllianceBernstein LPas of 30 Jun 20211.65m2.09%
Polen Capital Management LLCas of 30 Jun 20211.63m2.07%
Janus Capital Management LLCas of 30 Jun 20211.46m1.85%
JPMorgan Investment Management, Inc.as of 30 Jun 20211.46m1.85%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.